Revance Therapeutics
RVNC
$3.40
Share price
3.34%
Change (1 day)
-89.22%
Change (1 year)
Categories
Market capitalization of Revance Therapeutics (RVNC)
Market cap: $0.35 Billion
As of April 2024 Revance Therapeutics has a market cap of $0.35 Billion. This makes Revance Therapeutics the world's 6348th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Revance Therapeutics from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.35 B | -54.09% |
| 2023 | $0.77 B | -49.18% |
| 2022 | $1.51 B | 29.62% |
| 2021 | $1.17 B | -37.87% |
| 2020 | $1.88 B | 121.87% |
| 2019 | $0.85 B | 14.21% |
| 2018 | $0.74 B | -42.74% |
| 2017 | $1.29 B | 120.23% |
| 2016 | $0.59 B | -38.92% |
| 2015 | $0.96 B | 139.94% |
| 2014 | $0.40 B |
End of Day market cap according to different sources
On Apr 27th, 2024 the market cap of Revance Therapeutics was reported to be:
$0.29 Billion
$0.35 Billion
$0.35 Billion
$0.35 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.16 B | 99,287.82% | 🇺🇸 USA |
 Biogen BIIB | $30.41 B | 8,483.76% | 🇺🇸 USA |
 MediciNova MNOV | $64.25 M | -81.87% | 🇺🇸 USA |